Skip to content
Home/Companies/Biotech/Celea Therapeutics
Celea Therapeutics

Celea Therapeutics

Biotech·United States·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Celea Therapeutics?

Celea Therapeutics is an American Biotech company, currently owned by Leaps by Bayer since 2026.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitewww.celeatx.com

More from Leaps by Bayer

Other portfolio companies in the same fund.

Leaf Agriculture
Active
ClimateTechUS· 2026
Sabanto
Active
AgTechUS· 2026
SonoThera
SonoThera
Active
BiotechUS· 2026
Souffle Therapeutics
Active
BiotechUS· 2025
WellTheory
WellTheory
Active
HealthTechUS· 2025
CORXEL
Corxel
Active
PharmaChina· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Celea Therapeutics?

Celea Therapeutics is currently owned by Leaps by Bayer, through Leaps by Bayer, since 2026.

When did Leaps by Bayer acquire Celea Therapeutics?

Leaps by Bayer acquired Celea Therapeutics in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue